ACE inhibitors do not cause hypokalemia. They actually do the opposite: they raise potassium levels and can cause hyperkalemia (too much potassium in the blood). This is one of the most commonly confused side effects of these medications, likely because ACE inhibitors are often prescribed alongside diuretics that do lower potassium. Understanding which drug does what matters for your safety.
Why ACE Inhibitors Raise Potassium
ACE inhibitors work by blocking an enzyme that produces a hormone called angiotensin II. One of angiotensin II’s jobs is to trigger the release of aldosterone from the adrenal glands. Aldosterone tells the kidneys to hold onto sodium and flush out potassium. When an ACE inhibitor blocks this chain of events, aldosterone levels drop, less potassium gets excreted in the urine, and blood potassium levels rise.
This potassium-sparing effect is consistent and well documented. In the HOPE study, which followed over 9,200 patients at high cardiovascular risk, the ACE inhibitor ramipril actually reduced the rate of hypokalemia compared to placebo (1.15% vs. 1.86%). In other words, ACE inhibitors protect against low potassium rather than causing it.
How Common Is Hyperkalemia on ACE Inhibitors
The risk of elevated potassium varies depending on the patient population and how hyperkalemia is defined. In a retrospective study of 1,163 ACE inhibitor users, 20.4% had at least one potassium reading above 5.0 mEq/L over a one-year period. Severe hyperkalemia (6.0 mEq/L or higher) was much rarer, occurring in about 0.8% of users. In large randomized trials of patients with diabetes or vascular disease, the rate was lower, around 3.3% for ramipril users when defined as potassium above 5.5 mEq/L.
For most people, the increase in potassium is modest and stays within a safe range. But certain groups face higher risk:
- Chronic kidney disease: The kidneys are already less efficient at excreting potassium, so the additional effect of an ACE inhibitor can tip levels too high.
- Diabetes: Both type 1 and type 2 diabetes can impair the body’s ability to manage potassium.
- Heart failure: Reduced kidney blood flow and other medications used in heart failure treatment compound the risk.
- Advanced age: Kidney function naturally declines with age, making potassium accumulation more likely.
Where the Confusion Comes From
ACE inhibitors are frequently prescribed alongside thiazide diuretics (water pills) for blood pressure control. Thiazide diuretics cause the kidneys to excrete more potassium, which can lead to hypokalemia. When patients take both drugs together, they may associate the potassium drop with the ACE inhibitor rather than the diuretic.
In practice, this pairing is often intentional. The potassium-raising effect of the ACE inhibitor helps offset the potassium-lowering effect of the diuretic, keeping levels closer to normal. If a patient on a diuretic develops low potassium, adding an ACE inhibitor is one strategy clinicians use to restore balance without needing potassium supplements.
ACE Inhibitors vs. ARBs and Potassium
ARBs (angiotensin receptor blockers) work on the same hormonal system as ACE inhibitors but block angiotensin II at a different point. Both drug classes reduce aldosterone and raise potassium levels to a similar degree. In head-to-head trials, the rates of hyperkalemia are comparable: roughly 3.3% for ramipril (an ACE inhibitor) versus 3.4% for telmisartan (an ARB) in one large trial of over 25,000 patients. Combining both drugs increases the risk further, with hyperkalemia rates reaching 5.6% in the same study.
Potassium and Diet While Taking ACE Inhibitors
Because ACE inhibitors reduce potassium excretion, what you eat matters more than it would otherwise. Salt substitutes are a particular concern. Many of them replace sodium chloride with potassium chloride, and the potassium content varies widely, from about 440 mg to 2,800 mg per teaspoon. For someone on an ACE inhibitor with healthy kidneys, this may not cause problems. But for anyone with impaired kidney function, diabetes, or other risk factors, the extra potassium from a salt substitute on top of an ACE inhibitor can push levels into a dangerous range.
Potassium-rich foods like bananas, potatoes, and leafy greens don’t need to be eliminated, but people with kidney disease or multiple risk factors for hyperkalemia should be mindful of their total potassium intake from food, supplements, and salt substitutes combined. Routine blood work to check potassium levels is standard practice after starting an ACE inhibitor or adjusting the dose, especially in higher-risk patients.